Evidence map›Paper›PMID 36422332›Full record

ArticleMicroorganisms2022

Seroprevalence and Risk Factors Associated with

Maria Almeida, Carla Maia, José M Cristóvão, Cátia Morgado, Inês Barbosa, Ruben Foj Ibars, Lenea Campino, Luzia Gonçalves, Sofia Cortes

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. One health (Amsterdam, Netherlands) · 2026
    Article
  4. Article
  5. Article
  6. Community Drivers ofTropical medicine and infectious disease · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Seroprevalence ofMicroorganisms · 2026
    Article
  11. Article
  12. Seroprevalence, clinical investigation, and risk factors associated withJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2025
    Article
  13. Humoral and T-Cell-Mediated Immunity AgainstPathogens (Basel, Switzerland) · 2025
    Article
  14. An Update on Clinical and Pathogenic Spectra of Leishmaniasis.Expert reviews in molecular medicine · 2025
    Review
  15. Article
  16. Analysis of the Current Risk ofTransboundary and emerging diseases · 2025
    Article
  17. A climatic suitability indicator to supportThe Lancet regional health. Europe · 2024
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Maria AlmeidaInstituto de Higiene e Medicina Tropical (IHMT), Universidade Nova de Lisboa (UNL), Rua da Junqueira, 100, 1349-008 Lisboa, Portugal.
Carla MaiaInstituto de Higiene e Medicina Tropical (IHMT), Universidade Nova de Lisboa (UNL), Rua da Junqueira, 100, 1349-008 Lisboa, Portugal.ORCID 0000-0002-2545-7686
José M CristóvãoInstituto de Higiene e Medicina Tropical (IHMT), Universidade Nova de Lisboa (UNL), Rua da Junqueira, 100, 1349-008 Lisboa, Portugal.
Cátia MorgadoLETI Pharma S.L.U., 08038 Barcelona, Spain.
Inês BarbosaMSD Animal Health Lda, 2770-192 Paço de Arcos, Portugal.
Ruben Foj IbarsLETI Pharma S.L.U., 08038 Barcelona, Spain.ORCID 0000-0002-7047-4071
Lenea CampinoInstituto de Higiene e Medicina Tropical (IHMT), Universidade Nova de Lisboa (UNL), Rua da Junqueira, 100, 1349-008 Lisboa, Portugal.
Luzia GonçalvesInstituto de Higiene e Medicina Tropical (IHMT), Universidade Nova de Lisboa (UNL), Rua da Junqueira, 100, 1349-008 Lisboa, Portugal.ORCID 0000-0002-9710-1945
Sofia CortesInstituto de Higiene e Medicina Tropical (IHMT), Universidade Nova de Lisboa (UNL), Rua da Junqueira, 100, 1349-008 Lisboa, Portugal.ORCID 0000-0001-5850-6950
Universidade Nova de Lisboa · PTLight Prescriptions Innovators (Spain) · ESUniversity of Lisbon · PT

Funding

Fundação para a Ciência e Tecnologia UID/Multi/04413/2019 (GHTM)MSD Animal Health Lda. and LETI Pharma Vetleish project
6 · The paper itself

Abstract

Canine leishmaniosis (CanL) caused by

Indexed as

direct agglutination testdogsLeishmanialeishmaniasisPortugalrisk factorsseroprevalencesouthwestern Europe

Identifiers

PMID36422332
PMCPMC9695918
OpenAlexW4309033900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.